We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Permanent LVAS Implanted in Patient

By HospiMedica staff writers
Posted on 04 Aug 2004
The first patient permanently implanted with the Heartmate XVE left ventricular assist system (LVAS) at the University of Pittsburgh Medical Center (UPMC, PA, USA) was discharged in July 2004.

The implant was done as a permanent implant in lieu of a heart transplant, as opposed to the traditional bridge-to-transplant use for this kind of device. More...
The patient was a 58-year-old man with end-stage heart failure. Heartmate was developed by Thoratec (Pleasanton, CA, USA; www.thoratec.com) and has been approved by the U.S. Food and Drug Administration (FDA) for this kind of "destination therapy” in patients with end-stage heart failure who have a life expectancy of less then two years and are not viable candidates for heart transplantation.

The University of Pittsburgh is only one of two centers in western Pennsylvania approved to implant Heartmate XVE. "Heart transplantation is still the best option for long-term survival, but unfortunately, it is not feasible for everyone,” noted Robert L. Kormos, M.D., professor of surgery at the University of Pittsburgh School of Medicine and director of UPMC's artificial heart and heart transplant programs. "This new therapy allows us to return people to productive lives at home as an alternative to dying from end-stage congestive heart failure.”



Related Links:
UPMC
Thoratec

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Vessel Sealing Instrument
ERGOseal
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.